Egyptian Pharmaceuticals & Biotech Undervalued based on future growth

Results

0 new

Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)

2 companies

Egyptian International Pharmaceutical Industries

Market Cap: ج.م10.4b

Manufactures and sells pharmaceutical ampoules in Egypt and internationally.

PHAR

ج.م61.77

-4.5%

31.6%

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) (S.A.E)

Market Cap: ج.م6.1b

Produces and sells a range of branded generic pharmaceuticals, food supplements, veterinary products, and nutraceuticals in Egypt.

RMDA

ج.م4.06

-1.0%

45.5%